| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-16 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-15 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-14 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-12 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |